Sign in

CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Aura Biosciences, Inc.

Sign in to watch
Ticker
AURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320271970
Phone
(617)500-8864
Business address
80 GUEST STREET, BOSTON, MA, 02135
  1. 4 Grant or award Chief People Officer acquired 107,611 shares (grant or award)
  2. 4 Grant or award Chief Reg. & Quality Officer acquired 100,885 shares (grant or award)
  3. 4 Grant or award Chief Medical Officer acquired 58,850 shares (grant or award)
  4. 4 Grant or award SVP, Finance & PAO acquired 23,540 shares (grant or award)
  5. 4 Grant or award Chief Operating Officer acquired 134,513 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 30,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award See Remarks acquired 14,858 shares (grant or award)
  12. 4 Open-market sale See Remarks sold 12,824 shares at $6.42 ($82,330)
  13. 4 Grant or award Director acquired 15,000 shares (grant or award)
  14. 4 Grant or award Director acquired 15,000 shares (grant or award)
  15. 4 Grant or award Director acquired 15,000 shares (grant or award)
  16. 4 Grant or award Director acquired 15,000 shares (grant or award)
  17. 4 Grant or award See Remarks acquired 1,153,962 shares (grant or award)
  18. 4 Open-market sale 10% owner sold 6,922,870 shares at $5.64 ($39,044,987)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale See Remarks sold 11,738 shares at $7.02 ($82,401)

Page 1 of 7 · 136 filings